Personalized prognostic prediction model of intermittent treatment for chronic myeloid leukemia

摘要

The present invention is an invention that can provide various technologies for establishing a patient-specific mathematical modeling that can predict the recurrence pattern after secondary discontinuation of imatinib in chronic myeloid leukemia patients, which are different for each patient.